GNTA
Genenta Science SpA - ADR

19
Mkt Cap
$61.27M
Volume
2,169.00
52W High
$6.12
52W Low
$2.56
PE Ratio
-6.44
GNTA Fundamentals
Price
$3.29
Prev Close
$3.20
Open
$3.22
50D MA
$3.30
Beta
0.12
Avg. Volume
14,495.10
EPS (Annual)
-$0.5276
P/B
4.43
Rev/Employee
$0.00
Loading...
Loading...
Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. Its lead product candidate, Temferon, was developed using its platform and carries an interferon-alpha payload. The company was founded by Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner on July 24, 2014 and is headquartered in Milan, Italy.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
13

Frequently Asked Questions

What is Market Cap of Genenta Science SpA - ADR?
What is the 52-week high for Genenta Science SpA - ADR?
What is the 52-week low for Genenta Science SpA - ADR?
What is Genenta Science SpA - ADR stock price today?
What was Genenta Science SpA - ADR stock price yesterday?
What is the PE ratio of Genenta Science SpA - ADR?
What is the Price-to-Book ratio of Genenta Science SpA - ADR?
What is the 50-day moving average of Genenta Science SpA - ADR?
How many employess does Genenta Science SpA - ADR has?

Latest GNTA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.